Role of the pharmaceutical excipients in the tamoxifen activity on MCF-7 and vero cell cultures

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4529-4533

  Rossi, Tiziana ^a   Iannuccelli, Valentina ^a   Coppi, Gilberto ^a   Bruni, Elisa ^a   Baggio, Giosué ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Alginate chitosan microparticles; Bioavailability; MCF 7; Tamoxifen; Toxicity

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALGINIC ACID; CALCIUM ALGINATE; CHITOSAN; EXCIPIENT; TAMOXIFEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL STRAIN MCF 7; CYTOTOXICITY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LD 50; NONHUMAN; PRIORITY JOURNAL; VERO CELL;

ALGINATES; ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHITOSAN; EXCIPIENTS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; PARTICLE SIZE; TAMOXIFEN; VERO CELLS;

EID: 75149176273     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sterns V and Gelmann EP: Does tamoxifen cause cancer in human? J Clin Oncol 16: 779-792, 1998.
2. Jordan CV: Designer estrogens. Sci Am 279: 60-67, 1998.
3. Bryant HU and Dere WH: Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc Soc Ex̀p Biol Med 217: 45-52, 1998.
4. Kreuter J: Nanoparticles and microparticles for drug and vaccine delivery. J Anat 189: 503-505, 1996.
5. Brigger I, Chaminade P, Marsaud V, Appel M, Besnard M, Gurny R, Renoir M and Couvreur P: Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation. Int J Pharm 214: 37-42, 2001.
6. Coppi G, Iannuccelli V, Leo E, Bernabei MT and Cameroni R: Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm 27: 393-400, 2001.
7. Buchanan CM, Buchanan NL, Edgar KJ, Little JL, Malcolm MO, Ruble KM, Wacher VJ and Wempe MF: Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-cyclodextrin formulations. J Pharm Sci 96: 644-660, 2006.
8. Langley JM and Halperin SMD: Allergy to antibiotics in children: Perception versus reality. Can J Infect Dis 13(3): 160-163,2002.
9. Heaney DC and Sander JW: Antiepileptic drugs: generic versus branded treatments. Lancet Neurol 6: 465-8, 2007.
10. Birkett DJ: Generics - equal or not? Australian Prescriber 26: 85-87, 2003.
11. Mclachlan AJ, Ramzan I and Milne RW: Frequently asked questions about generic medicines. Australian Prescriber 30: 41-47, 2007.
12. Coppi G and Iannuccelli V: Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. Intl J Pharmaceut 367: 127-132, 2009.
13. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983.
14. George M and Abraham TE: Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J Control Release 114(1): 1-14, 2006.
15. Majumdar K, Valdellon JA and Brown KAJ: In vitro investigations on the toxicity and cell death induced by tamoxifen on two non-breast cancer cell types. S Biomed Biotechnol 1(3): 99-107, 2001.
16. Perry RR, Kang Y and Greaves B: Effects of tamoxifen on growth and apoptosis of estrogen-dependent and independent human breast cancer cells. Ann Surg Oncol 2: 238-245, 1995.
17. Osborne CK, Boldt D, Clark GM and Trent JM: Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G-I phase. Cancer Res 43: 3583-3585, 1993.
18. Petinari L, Kohn LK, De Carvalho JE and Genari SC: Cytotoxicity of tamoxifen in normal and tumoral cell lines and its ability to induce cellular transformation in vitro. Cell Biol Int 28: 531-539, 2004.
19. Kawada A, Hiura N, Tajima S and Takahara H: Alginate oligosaccharides stimulate VEGF-mediated growth and migration of human endothelial cells. Arch Dermatol Res 291: 542-547, 1999.
20. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG and Wolmark N: Tamoxifen for the Prevention of Breast Cancer. Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Nat Cancer Institute 97(22): 1652-1662, 2005.
21. George M and Abraham TE: Polyionic hydrocolloids for the intestinal delivery of protein drugs. Alginate and chitosan - a review. J Control Release 114: 1-14, 2006.
22. Borges O, Borchard G, De Sousa A, Junginger HE and Cordeiroda-Silva A: Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers. Int J Pharm 337: 254-264, 2007.
23. Stokke BT, Draget KI, Smidsrød O, Yuguchi Y, Urakawa H and Kajiwara K: Small-angle X-ray scattering and rheological characterization of alginate gels. 1. Ca-alginate gels. Macromolecules 33: 1853-1863, 2000.